RESUMEN
There are many limitations in evaluating vaccine efficacy by comparing the incidence of clinical endpoint events (such as morbidity, bacterial colonization) between the vaccine group and the control group. Therefore, the researchers put forward the concept of Surrogate of protection to predict vaccine protection with immunological indicators. In 2012, WHO put forward the immunological substitution endpoint of pneumococcal vaccine, using 0. 35 μg/ml as the protective antibody level of pneumococcal vaccine. But subsequent studies have found that using this threshold to assess all vaccine serotypes may not be accurate.
RESUMEN
Genes play an important role in the immune system response,and different gene loci may result in different vaccine immune response rates.This review focuses on the correlation between gene polymorphisms and vaccine immune response in order to investigate the influence of gene polymorphisms on the immune response to vaccines.It discusses the effect of an individual's immune response after vaccination at genetic level and provides a scientific basis for individualized immune development strategies.It reveals that human leukocyte antigen genes,various cytokines and their receptor genes,and Toll-like receptor genes all affect the vaccine immune response.
RESUMEN
Genes play an important role in the immune system response,and different gene loci may result in different vaccine immune response rates.This review focuses on the correlation between gene polymorphisms and vaccine immune response in order to investigate the influence of gene polymorphisms on the immune response to vaccines.It discusses the effect of an individual's immune response after vaccination at genetic level and provides a scientific basis for individualized immune development strategies.It reveals that human leukocyte antigen genes,various cytokines and their receptor genes,and Toll-like receptor genes all affect the vaccine immune response.